Testmate Health has successfully closed an oversubscribed seed round of 1.62 million CHF
Testmate Health has successfully closed an oversubscribed seed round of 1.62 million CHF, with the first closing occurring earlier this spring and the round extended to bring in U.S. based & women's health focused VC Rhia Ventures
. In addition to Rhia Ventures
, Testmate Health also welcome the fund Next Ventures for Humanity alongside a host of wonderful angels.
Testmate Health also welcome Thomas Zehnder
onto our Board of Directors and Elizabeth Bailey
as Board Observer. With their deep MedTech industry expertise across both sides of the Atlantic, they will guide Testmate Health through the next stages.
With the funds, Testmate Health plans to accelerate product development & complete pre-clinical studies of their device.